Sun Gao-bin, Huang Zong-hai, Sun Ying-gang, Yang Wen-yu
Department of General Surgery, Zhujiang Hospital, First Military Medical University, Guangzhou 510282, China.
Di Yi Jun Yi Da Xue Xue Bao. 2003 Apr;23(4):306-9.
To evaluate the effects of a selective inhibitor of inducible nitric oxide synthase (iNOS) aminoguanidine (AG) and a non-selective inhibitor of nitric oxide synthase (NOS) N(G)-nitro-L-arginine methylester (L-NAME) on traumatic shock in rats.
Animal models of traumatic shock were established in 44 Sprague-Dawley rats following fractures in both femur shafts and subsequent depletion until the mean arterial pressure in the femoral artery dropped to 35 to 45 mmHg(4.67-6.00 kPa). Hypotension was maintained for 30 min before the collected blood was infused back into the rats supplemented with Ringer's solution of the same volume. The rat models were then randomly divided into 3 groups, namely traumatic shock group (n=10), AG group (which was subdivided into AGI, AGII, and AGIII groups, each consisting of 8 rats and receiving 2, 8, and 60 mg/kg x b.w AG infusion respectively during resuscitation), and L-NAME group (with 8 mg/kg x b.w L-NAME infusion during resuscitation, n=10). Plasma NO levels were determined before and after shock, immediately after resuscitation and 0.5, 2, 4 h after resuscitation, and the survival rates within 24 h were recorded with tissue samples of the lung, liver, kidney and intestine obtained 24 h after shock for microscopic examination.
Plasma NO level was seen to increase markedly after traumatic shock in the rat models. In the 3 AG groups, the elevated NO levels following the shock were obviously reduced after resuscitation with less tissue damages and higher survival rates, as compared with the other 2 groups. The best protective effect against traumatic shock was observed in AGIII group. In spite of obvious plasma NO level-lowering effect after resuscitation, L-NAME exhibited little efficacy in alleviating the tissue damages in the organs and hence failed to improve the survival rate of the rats.
NO plays an important role in the pathological process of traumatic shock, and the application of AG may improve the condition. L-NAME can decrease plasma NO level after resuscitation, but fail to improve the outcome of traumatic shock in rats.
评估诱导型一氧化氮合酶(iNOS)选择性抑制剂氨基胍(AG)和一氧化氮合酶(NOS)非选择性抑制剂N(G)-硝基-L-精氨酸甲酯(L-NAME)对大鼠创伤性休克的影响。
对44只Sprague-Dawley大鼠建立创伤性休克动物模型,方法是双侧股骨干骨折,随后放血直至股动脉平均动脉压降至35至45 mmHg(4.67 - 6.00 kPa)。低血压维持30分钟后,将收集的血液回输到大鼠体内,并补充相同体积的林格氏液。然后将大鼠模型随机分为3组,即创伤性休克组(n = 10)、AG组(分为AGI、AGII和AGIII组,每组8只大鼠,复苏期间分别接受2、8和60 mg/kg体重的AG输注)和L-NAME组(复苏期间接受8 mg/kg体重的L-NAME输注,n = 10)。在休克前后、复苏后即刻以及复苏后0.5、2、4小时测定血浆NO水平,并记录24小时内的存活率,同时在休克后24小时获取肺、肝、肾和肠的组织样本进行显微镜检查。
在大鼠模型中,创伤性休克后血浆NO水平明显升高。在3个AG组中,与其他2组相比,复苏后休克后升高的NO水平明显降低,组织损伤较轻,存活率较高。AGIII组对创伤性休克的保护作用最佳。尽管复苏后L-NAME有明显降低血浆NO水平的作用,但在减轻器官组织损伤方面效果不佳,因此未能提高大鼠的存活率。
NO在创伤性休克的病理过程中起重要作用,应用AG可能改善病情。L-NAME可在复苏后降低血浆NO水平,但未能改善大鼠创伤性休克的结局。